EF5: Clinical Trials

4 trials of EF5, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4

Follow EF5: new trials by email Literature Review of EF5 trials Research Report on EF5

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer
EF5 - Primary Peritoneal Cavity Cancer, Stage I Endometrial Carcinoma
Phase 2CompletedNational Cancer Institute (NCI)602005-02-012013-01-16
EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer
EF5, bioluminescence, flow cytometry - Head and Neck Cancer
Phase 2CompletedDavid M. Brizel, MD82002-08-012014-07-25
EF5 in Assessing Tumor Response to Anticancer Therapy in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
EF5, flow cytometry, immunohistochemistry staining method - Lung Cancer
Phase 2CompletedDuke University602002-05-012015-05-01
EF5 in Measuring Tumor Hypoxia in Patients With Stage I-III Non-Small Cell Lung Cancer
EF5, Laboratory Biomarker Analysis, Therapeutic Conventional Surgery - Stage IA Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma
Phase 2CompletedNational Cancer Institute (NCI)282002-05-012015-04-13

Conditions studied

Carcinoma, Non-Small-Cell Lung (2)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Endometrial Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Salivary Gland Neoplasms (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)  ·  Uterine Cervical Neoplasms (1)

Sponsors

National Cancer Institute (NCI) (2)  ·  David M. Brizel, MD (1)  ·  Duke University (1)

Countries

United States (4)

Top investigators

Christina Chu (1)  ·  David M. Brizel, MD (1)  ·  Michael J. Kelley, MD (1)  ·  Michael Kelley (1)

NIH funding

P30CA014236 (1), R21CA091565 (1), R21CA099346 (1)